Stay updated on Tavo in Melanoma Post-Checkpoint Inhibitors Clinical Trial
Sign up to get notified when there's something new on the Tavo in Melanoma Post-Checkpoint Inhibitors Clinical Trial page.

Latest updates to the Tavo in Melanoma Post-Checkpoint Inhibitors Clinical Trial page
- Check3 days agoChange DetectedThe page’s technical release indicator updates from “Revision: v3.5.2” to “Revision: v3.5.3,” reflecting a site software/version change rather than any change to the clinical trial record.SummaryDifference0.0%

- Check10 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2.SummaryDifference0.0%

- Check17 days agoNo Change Detected
- Check31 days agoChange DetectedThe location entry for Italy was updated from Napoli, Italy, 80131 to Naples, Italy, 80131.SummaryDifference0.0%

- Check39 days agoChange DetectedRevision updated from v3.4.3 to v3.5.0. This appears to be a system-wide update and does not affect study details.SummaryDifference0.0%

- Check46 days agoChange DetectedRevision: v3.4.3 was added and Revision: v3.4.2 was removed.SummaryDifference0.0%

- Check67 days agoChange DetectedThe new screenshot shows only minor UI/layout adjustments with no changes to essential study information such as eligibility criteria, enrollment, or primary outcomes. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

Stay in the know with updates to Tavo in Melanoma Post-Checkpoint Inhibitors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Tavo in Melanoma Post-Checkpoint Inhibitors Clinical Trial page.